Skip to main content
Equibles

MORGAN STANLEY

Position in NNVC — Nanoviricides, Inc.

CIK 895421 NEW YORK, NY
Back to NNVC Full portfolio

Position in NNVC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,610
+$1,230 QoQ
Shares Held
2,616
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 48 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NNVC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. NNVC ranks #444 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in NNVC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,610 2,616
2026-03-31 $2,380 2,616
2025-12-31 $21,075 18,651
2025-09-30 $2,784 1,947
2025-06-30 $2,725 1,947
2025-03-31 $135 116
2024-12-31 $165 116
2024-09-30 $391 261
2024-06-30 $2,168 1,261
2024-03-31 $274 237
2023-12-31 $241 237
2023-09-30 $317 237
2023-06-30 $272 237
2023-03-31 $101 87
2022-12-31 $96 87
2022-09-30 $41,120 23,769
2022-06-30 $231 123
2022-03-31 $1,587 760
2021-12-31 $4,846 1,303
2021-09-30 $16,021 3,453
2021-06-30 $16,017 3,452
2021-03-31 $16,293 3,452
2020-12-31 $23,539 8,202
2020-09-30 $113,217 29,484
2020-06-30 $408,639 54,631
2020-03-31 $266,777 46,477